← Back to Search

Procedure

Implantoplasty for Peri-Implant Mucositis

Q: Is this trial open to individuals younger than fifty years of age?

Eligible patients for this research must be at least 18 and no older than 80 years of age.

Q: Can I join as a volunteer for this medical investigation?

To qualify for this study, applicants should have peri-implantitis and be between 18 and 80 years old. A maximum of 30 participants will be admitted into the trial.

Q: Are participants currently being admitted into this trial?

Clinicialtrials.gov currently indicates that this medical study is actively recruiting participants; the protocol was initially posted on September 5th 2023 and recently updated on the 25th of the same month.

Q: What is the current threshold of participants being accepted into this investigation?

Affirmative. Clinicaltrials.gov records show that this study, which was opened on September 5th 2023, is actively recruiting participants. The research site needs to recruit 30 individuals from 1 clinic.

N/A

Waitlist Available

Led By Andrea Ravida

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Previously treated implants must have probing depths (PD) ≤ 4 mm

Patients must have been treated previously for peri-implantitis with or without IP, with at least 1 thread or 2 mm of implant surface exposed in the oral cavity.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 21 and 42 days

Awards & highlights

Study Summary

This trial will compare how well implants treated with/without a procedure heal mouth inflammation.

Who is the study for?

This trial is for adults aged 18-80 in good health, with specific dental implants previously treated for peri-implantitis. Participants should have minimal bacteria on the implant, stable bone levels around it, and healthy gums. Excluded are those with active infections, certain medical conditions requiring premedication before dental visits, pregnant women or those planning pregnancy, heavy smokers, and individuals on significant drug therapy.Check my eligibility

What is being tested?

The study aims to compare the healing process of gum inflammation around dental implants (PIM) that were previously smoothed down (IP) versus not. It will look at clinical signs of healing as well as immune response and bacterial changes during the development and resolution of PIM.See study design

What are the potential side effects?

As this trial involves inducing and resolving gum inflammation experimentally around implants rather than testing a medication or device with systemic effects, side effects are expected to be localized to the mouth area such as temporary swelling or discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My dental implants have a probing depth of 4 mm or less.

Select...

I have been treated for gum disease around my dental implant, exposing part of it.

Select...

I am between 18 and 80 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 21 and 42 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 21 and 42 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 21 and 42 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in the modified Gingival Index (mGI) between 21 and 42 days

Secondary outcome measures

Changes in probing depth (PD)

Marginal bone loss (MBL)

Microbiological profile of the biofilm analysis

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Implants with history of peri-implantitisExperimental Treatment2 Interventions

Implant(s) treated previously for peri-implantitis with or without exposed polished surface, no PD > 4 mm and < 50% bone loss.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor

1,719 Previous Clinical Trials

16,342,311 Total Patients Enrolled

1 Trials studying Peri-Implantitis

150 Patients Enrolled for Peri-Implantitis

Andrea RavidaPrincipal InvestigatorUniversity of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial open to individuals younger than fifty years of age?

"Eligible patients for this research must be at least 18 and no older than 80 years of age."

Answered by AI

Can I join as a volunteer for this medical investigation?

"To qualify for this study, applicants should have peri-implantitis and be between 18 and 80 years old. A maximum of 30 participants will be admitted into the trial."

Answered by AI

Are participants currently being admitted into this trial?

"Clinicialtrials.gov currently indicates that this medical study is actively recruiting participants; the protocol was initially posted on September 5th 2023 and recently updated on the 25th of the same month."

Answered by AI

What is the current threshold of participants being accepted into this investigation?

"Affirmative. Clinicaltrials.gov records show that this study, which was opened on September 5th 2023, is actively recruiting participants. The research site needs to recruit 30 individuals from 1 clinic."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without Implantoplasty

Andrea Ravida 2023. "Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without Implantoplasty". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06063876.

All > Experimental